PAR PHARMACEUTICAL COMPANIES, INC.

Inactive Instrument

Par Pharmaceutical Companies, Inc. Stock

Stocks

US69888P1066

Pharmaceuticals

End-of-day quote NYSE Other stock markets
- ^USD	-

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Latest news : Par Pharmaceutical Companies, Inc.

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Press Releases: Par Pharmaceutical Companies, Inc.

13-01-18	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR	PU
13-01-02	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets	PU
12-12-05	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®	PU
12-11-30	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®	PU
12-10-29	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.	PU

More press releases

News in other languages: Par Pharmaceutical Companies, Inc.

15-05-18	Endo rachète Par Parma pour créer un géant des génériques
15-05-18	Altera : Wall Street débute la semaine sans tendance
15-05-18	Wall Street débute la semaine sans tendance
15-05-18	Accenture : Les valeurs à suivre sur les marchés américains
15-05-18	Endo : rachète le génériqueur Par Pharmaceuticals

Managers and Directors: Par Pharmaceutical Companies, Inc.

Manager	Title	Age	Since
Paul Campanelli CEO	Chief Executive Officer	64	2012-08-31

Director	Title	Age	Since
Paul Campanelli BRD	Director/Board Member	64	2012-08-31

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	+1.09%	+2.33%	+8.02%	+83.51%	45.7B
	OTSUKA HOLDINGS CO., LTD.	+1.84%	+5.33%	+51.00%	+95.59%	34B
	CIPLA LIMITED	-1.63%	-1.87%	-11.54%	+34.27%	11.73B
	ZYDUS LIFESCIENCES LIMITED	-1.60%	-4.00%	+8.93%	+92.61%	11.48B
	KRKA, D. D.	+1.54%	+3.12%	+39.68%	+130.57%	9.28B
	GEDEON RICHTER	-0.92%	-0.17%	+16.72%	+40.48%	7.21B
	ONO PHARMACEUTICAL CO., LTD.	+1.00%	+1.54%	+43.89%	-17.43%	6.62B
	GLENMARK PHARMACEUTICALS LIMITED	-0.93%	-3.30%	+26.92%	+232.57%	6.44B
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.63%	-3.58%	-37.81%	-7.82%	5.01B
	Average	-0.03%	-0.04%	+16.20%	+76.04%	15.27B
	Weighted average by Cap.	+0.58%	+0.50%	+20.59%	+82.77%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!